Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatmentn         in women with advanced breast cancer

首页> 外文期刊>Annals of Oncology >Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatmentn in women with advanced breast cancer

【24h】

Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatmentn in women with advanced breast cancer

机译：比较多西紫杉醇联合表柔比星与多西紫杉醇联合卡培他滨作为一线治疗晚期乳腺癌妇女的Ⅲ期随机试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: The purpose of this study was to compare docetaxel plus epirubicin versus docetaxel plus capecitabine combinations as front-line treatment in women with advanced breast cancer (ABC).

机译：背景：本研究的目的是比较多西他赛加表柔比星与多西他赛加卡培他滨的组合作为晚期乳腺癌（ABC）妇女的一线治疗方法。

著录项

来源
《Annals of Oncology》 |2010年第1期|p.48-54|共7页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer. [J] . Mavroudis D, Papakotoulas P, Ardavanis Annals of oncology: official journal of the European Society for Medical Oncology . 2010,第1期

机译：比较多西他赛加表柔比星与多西他赛加卡培他滨作为晚期乳腺癌妇女的一线治疗的随机III期试验。
2. 4BA A randomized phase III study comparing epirubicin, docetaxel, and capecitabine (EDC) to epirubicin and docetaxel (ED) as neoadjuvant treatment for early breast cancer - first results of the Austrian Breast and Colorectal Cancer Study Group-Trial 24 (ABCSG-24) [J] . G.G.Steger, R.Greil, R.Jakesz, European Journal of Cancer Supplements . 2009,第3期

机译：4BA一项随机III期研究，比较了表柔比星，多西紫杉醇和卡培他滨（EDC）与表柔比星和多西紫杉醇（ED）作为早期乳腺癌的新辅助治疗-奥地利乳腺癌和结直肠癌研究组第24次试验（ABCSG-24）的初步结果
3. Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial. [J] . Blohmer JU, Schmid P, Hilfrich J, Annals of oncology: official journal of the European Society for Medical Oncology . 2010,第7期

机译：表柔比星和环磷酰胺与表柔比星和多西紫杉醇作为转移性乳腺癌妇女的一线治疗：一项随机III期试验的最终结果。
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Is there an app for that? An exploratory randomized controlled trial of app-based mindfulness training for women with breast cancer. [D] . Rosen, Kristen D. 2016

机译：有针对这样的应用吗？基于应用程序的正念训练对乳腺癌女性的探索性随机对照试验。
6. Docetaxel maintenance therapy versus best supportive care after first-line chemotherapy with different dose docetaxel plus cisplatin for advanced non-small cell lung cancer (TFINE study CTONG-0904): an open-label randomized phase III trial [O] . Li Zhang, Shun Lu, Ying Cheng, 2021

机译：多西紫杉醇维护治疗与不同剂量DOCETAXEL加顺铂的先进非小细胞肺癌（TFINE-0904）：开放标签随机第三阶段试验
7. RANDOMIZED PHASE III TRIAL COMPARING EPIRUBICIN/ DOXORUBICIN PLUS DOCETAXEL AND EPIRUBICIN/ DOXORUBICIN PLUS PACLITAXEL AS FIRST LINE TREATMENT IN WOMEN WITH ADVANCED BREAST CANCER [O] . Seema Devi, Yogesh Kumar Sharma, Dilip Shah 2021

机译：随机阶段III试验比较EPIRUBICIN / DOXORUBICIN PLUS DOCETAXEL和EPIRUBICIN / DOXORUBICIN PLUS PACLITAXEL作为晚期乳腺癌妇女的第一线治疗

Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatmentn in women with advanced breast cancer

摘要

著录项

相似文献

相关主题

期刊订阅